目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Biosimilar Contract Manufacturing Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Biosimilar Contract Manufacturing Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape

Chapter 4. Biosimilar Contract Manufacturing Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Biosimilar Contract Manufacturing Market: Product Movement Analysis, USD Million, 2023 & 2030
4.3. Recombinant Non-Glycosylated Proteins
4.3.1. Recombinant Non-Glycosylated Proteins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Recombinant Glycosylated Proteins
4.4.1. Recombinant Glycosylated Proteins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Biosimilar Contract Manufacturing Market: Production Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Biosimilar Contract Manufacturing Market: Production Technology Movement Analysis, USD Million, 2023 & 2030
5.3. Mammalian
5.3.1. Mammalian Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Non-Mammalian
5.4.1. Non-Mammalian Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Biosimilar Contract Manufacturing Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Biosimilar Contract Manufacturing Market: Application Movement Analysis, USD Million, 2023 & 2030
6.3. Oncology
6.3.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Blood Disorders
6.4.1. Blood Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Growth Hormonal Deficiency
6.5.1. Growth Hormonal Deficiency Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Rheumatoid Arthritis
6.6.1. Rheumatoid Arthritis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Chronic and Autoimmune Disorders
6.7.1. Chronic and Autoimmune Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Others
6.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Biosimilar Contract Manufacturing Market: Regional Estimates & Trend Analysis
7.1. Biosimilar Contract Manufacturing Market Share, By Region, 2023 & 2030, USD Million,
7.2. North America
7.2.1. North America Biosimilar Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U. S.
7.2.2.1. U. S. Biosimilar Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Biosimilar Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Mexico Biosimilar Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Biosimilar Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. UK Biosimilar Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Biosimilar Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. France Biosimilar Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Italy Biosimilar Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Spain Biosimilar Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Denmark Biosimilar Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Sweden Biosimilar Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Norway Biosimilar Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Biosimilar Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Japan Biosimilar Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. China
7.4.3.1. China Biosimilar Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. India Biosimilar Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. South Korea Biosimilar Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Australia Biosimilar Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Thailand Biosimilar Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Biosimilar Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Biosimilar Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Argentina
7.5.3.1. Argentina Biosimilar Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Biosimilar Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. Saudi Arabia
7.6.2.1. Saudi Arabia Biosimilar Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. South Africa
7.6.3.1. South Africa Biosimilar Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. UAE Biosimilar Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Kuwait Biosimilar Contract Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Boehringer Ingelheim Biopharmaceuticals GmbH
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. Lonza
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. Catalent, Inc.
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Biocon
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. IQVIA Inc.
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. AGC Biologics
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. WuXi Biologics
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. Element Materials Technology
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. Rentschler Biopharma SE
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. Avid Bioservices, Inc.
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives
8.4.11. Samsung Biologics
8.4.11.1. Participant’s Overview
8.4.11.2. Financial Performance
8.4.11.3. Product Benchmarking
8.4.11.4. Recent Developments/ Strategic Initiatives
8.4.12. Alcami Corporation, Inc.
8.4.12.1. Participant’s Overview
8.4.12.2. Financial Performance
8.4.12.3. Product Benchmarking
8.4.12.4. Recent Developments/ Strategic Initiatives
8.4.13. Fujifilm Kyowa Kirin Biologics Co., Ltd.
8.4.13.1. Participant’s Overview
8.4.13.2. Financial Performance
8.4.13.3. Product Benchmarking
8.4.13.4. Recent Developments/ Strategic Initiatives
8.4.14. Thermo Fisher Scientific Inc.
8.4.14.1. Participant’s Overview
8.4.14.2. Financial Performance
8.4.14.3. Product Benchmarking
8.4.14.4. Recent Developments/ Strategic Initiatives
8.4.15. Almac Group
8.4.15.1. Participant’s Overview
8.4.15.2. Financial Performance
8.4.15.3. Product Benchmarking
8.4.15.4. Recent Developments/ Strategic Initiatives